Rat No. |
Sex |
Treatment |
Location |
Days from implant |
Description |
3 |
F |
Control |
Adrenal |
363 |
Medulla hyperplasia of the adrenal |
9a |
F |
Naltrexone |
Pituitary |
477 |
Nodular hyperplasia in the pars distalis |
9b |
F |
Naltrexone |
Adrenal |
477 |
Medulla hyperplasia of the adrenal |
10 |
F |
Control |
Adrenal |
363 |
Focal nodular hyperplasia in the cortex of the adrenal |
18 |
F |
Placebo |
Thyroid |
563 |
Unilateral nodular hyperplasia in the thyroid |
23 |
F |
Control |
Pituitary |
563 |
Nodular hyperplasia in the pars distalis |
31 |
M |
Control |
Pituitary |
479 |
Nodular hyperplasia in the pars distalis |
42 |
M |
Control |
Pituitary |
517 |
Nodular hyperplasia in the pars distalis |
44 |
M |
Placebo |
Pituitary |
517 |
Nodular hyperplasia in the pars distalis |
49 |
M |
Control |
Adrenal |
477 |
Medulla hyperplasia of the adrenal |